Purpose To assess the utility of precise radiologic and pathologic correlation for establishing
imaging-histologic concordance or discordance as a method to limit the number of patients …

OBJECTIVE. The purpose of this article is to determine the upgrade rate to ductal carcinoma
in situ (DCIS) or invasive carcinoma at excision at the same site after percutaneous breast …

OBJECTIVE. The aims of our study were to determine the frequency of malignancy after
surgical excision of biopsy-proven lobular carcinoma in situ (LCIS) or atypical lobular …

The appropriate follow-up and treatment for patients with a core biopsy diagnosis of lobular
neoplasia (atypical lobular hyperplasia or lobular carcinoma in situ) remains controversial …

Lobular neoplasia including lobular carcinoma in situ (LCIS) and atypical lobular
hyperplasia (ALH) may be identified in breast core needle biopsies as incidental findings or …

PURPOSE: To review outcomes of lesions diagnosed at core-needle breast biopsy as
atypical lobular hyperplasia (ALH) or lobular carcinoma in situ (LCIS). MATERIALS AND …

There are no consensus guidelines for the management of lobular neoplasia diagnosed on
core biopsy as the highest risk factor for cancer. This study aimed to assess the risk of …

Purpose Controversy surrounds management of lobular neoplasia (LN),[atypical lobular
hyperplasia (ALH) or lobular carcinoma in situ (LCIS)], diagnosed on core needle biopsy …

BACKGROUND: Atypical lobular hyperplasia and classic-type lobular carcinoma in situ,
collectively known as lobular neoplasia, are classically described as incidental findings …

Background Lobular neoplasia (LN) includes atypical lobular hyperplasia (ALH) and lobular
carcinoma in situ (LCIS). LN often is an incidental finding on breast core needle biopsy …